Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Norbert, Ndjeka"'
Autor:
Keri Geiger, Amita Patil, Chakra Budhathoki, Kelly E Dooley, Kelly Lowensen, Norbert Ndjeka, Jacqueline Ngozo, Jason E Farley
Publikováno v:
PLOS Global Public Health, Vol 4, Iss 5, p e0002714 (2024)
The impact of HIV viral suppression on multidrug resistant tuberculosis (MDR-TB) treatment outcomes among people with HIV (PWH) has not been clearly established. Using secondary data from a cluster-randomized clinical trial among people with MDR-TB i
Externí odkaz:
https://doaj.org/article/9c4f3d3a61e549c6ba7d8cad6775108b
Autor:
Aastha Gupta, Sandeep Juneja, Victor Babawale, Nurov Rustam Majidovich, Norbert Ndjeka, Phuong Thi Mai Nguyen, Parpieva Nargiza Nusratovna, David Robert Omanito, Tiffany Tiara Pakasi, Yana Terleeva, Atyrkul Toktogonova, Yasir Waheed, Zaw Myint, Zhao Yanlin, Suvanand Sahu
Publikováno v:
PLoS ONE, Vol 19, Iss 1, p e0296448 (2024)
BackgroundThe WHO has issued a call to action urging countries to accelerate the rollout of new WHO-recommended shorter all-oral treatment regimens for drug-resistant TB (DR-TB), which remains a public-health crisis. The all-oral, 6-month BPaL/M regi
Externí odkaz:
https://doaj.org/article/cf23ba824ee74c98a649db26868bb739
Autor:
Waasila Jassat, Caroline Mudara, Caroline Vika, Richard Welch, Tracy Arendse, Murray Dryden, Lucille Blumberg, Natalie Mayet, Stefano Tempia, Arifa Parker, Jeremy Nel, Rubeshan Perumal, Michelle J. Groome, Francesca Conradie, Norbert Ndjeka, Louise Sigfrid, Laura Merson, Cheryl Cohen
Publikováno v:
International Journal of Infectious Diseases, Vol 128, Iss , Pp 102-111 (2023)
ABSTRACT: Objectives: The study aimed to describe the prevalence of and risk factors for post-COVID-19 condition (PCC). Methods: This was a prospective, longitudinal observational cohort study. Hospitalized and nonhospitalized adults were randomly se
Externí odkaz:
https://doaj.org/article/57684fdf5239460db9d21d21dc599916
Autor:
Koleka Mlisana, John Black, Alison Grant, Marian Loveday, Karina Kielmann, Mosa Moshabela, Helen Cox, Jeremy Hill, Norbert Ndjeka, Mark Nicol, Waasila Jassat, Sacha Roxanne Le Roux, Lindy Dickson, Leila Mitrani
Publikováno v:
BMJ Open, Vol 13, Iss 11 (2023)
Objectives Treatment for multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) is increasingly transitioning from hospital-centred to community-based care. A national policy for decentralised programmatic MDR/RR-TB care was adopted in Sou
Externí odkaz:
https://doaj.org/article/7c0368a329e44527ab2ed612db73f620
Autor:
Helen Pai, Norbert Ndjeka, Lawrence Mbuagbaw, Koné Kaniga, Eileen Birmingham, Gary Mao, Lori Alquier, Kourtney Davis, Arianne Bodard, Abeda Williams, Magalie Van Tongel, Florence Thoret-Bauchet, Shaheed V. Omar, Nyasha Bakare
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-15 (2022)
Abstract Background This retrospective cohort study assessed benefits and risks of bedaquiline treatment in multidrug-resistant-tuberculosis (MDR-TB) combination therapy by evaluating safety, effectiveness, drug utilization and emergence of resistanc
Externí odkaz:
https://doaj.org/article/94c70ff528f247768fe1de8d76f8e035
Autor:
Jason E. Farley, Norbert Ndjeka, Khaya Mlandu, Kelly Lowensen, Keri Geiger, Yen Nguyen, Chakra Budhathoki, Paul D. Stamper
Publikováno v:
Human Resources for Health, Vol 19, Iss 1, Pp 1-7 (2021)
Abstract Background Treatment for rifampicin-resistant Mycobacterium tuberculosis (RR-TB) is complex, however, shorter treatment, with newer antimicrobials are improving treatment outcomes. The South African National Department of Health (NDoH) recen
Externí odkaz:
https://doaj.org/article/e7a938796e66451fbd6f529472d87d14
Autor:
Francesca Conradie, Anna Vassall, Norbert Ndjeka, Gabriela Beatriz Gomez, Mariana Siapka, Anna Marie Celina Garfin, Nino Lomtadze, Zaza Avaliani, Nana Kiria, Shelly Malhotra, Sarah Cook-Scalise, Sandeep Juneja, Daniel Everitt, Melvin Spigelman
Publikováno v:
BMJ Open, Vol 11, Iss 12 (2021)
Externí odkaz:
https://doaj.org/article/34e7c4ff8d494dee9d5db81d5f531aa8
Autor:
Norbert Ndjeka, Nazir A Ismail
Publikováno v:
The Lancet Microbe, Vol 1, Iss 4, Pp e139-e140 (2020)
Externí odkaz:
https://doaj.org/article/144b6399bbd4410a8af8738cd890e720
Autor:
Jonathon R. Campbell, Dennis Falzon, Fuad Mirzayev, Ernesto Jaramillo, Giovanni Battista Migliori, Carole D. Mitnick, Norbert Ndjeka, Dick Menzies
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 3, Pp - (2020)
International policy for treatment of multidrug- and rifampin-resistant tuberculosis (MDR/RR TB) relies largely on individual patient data (IPD) from observational studies of patients treated under routine conditions. We prepared guidance on which da
Externí odkaz:
https://doaj.org/article/57a34cf2f3ba42419da479e0fbd81cd0
Autor:
Brittany K Moore, Linda Erasmus, Julia Ershova, Sarah E Smith, Norbert Ndjeka, Laura J Podewils
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0230504 (2020)
Multidrug-resistant (MDR) TB is more difficult to diagnose and treat compared with drug-susceptible TB. Young children are at greater risk of severe TB disease and death when treatment is delayed compared to adults. We sought to describe characterist
Externí odkaz:
https://doaj.org/article/5828babd9811452590a7653b52a51bd0